{
    "2019-04-15": [
        [
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)一季度净利升44.02%至1.3亿元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "一季度",
                        "净利",
                        "44.02%",
                        "1.3亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健帆生物：一季度净利润同比增44.02%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "一季度",
                        "净利润",
                        "同比增",
                        "44.02%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}